Do statins help erectile dysfunction? This question concerns many men prescribed these cholesterol-lowering medications. Statins are amongst the most commonly prescribed drugs in the UK for cardiovascular risk reduction. Whilst some men worry about potential sexual side effects, the relationship between statins and erectile function is more complex than often assumed. Emerging evidence suggests statins may actually improve erectile function in some men by enhancing blood vessel health. Understanding this connection requires examining how cardiovascular health, cholesterol levels, and blood flow affect erectile function, alongside the latest clinical evidence and guidance from NICE and NHS sources.

Understanding the Link Between Statins and Erectile Dysfunction

Statins are among the most widely prescribed medications in the UK, primarily used to lower cholesterol levels and reduce cardiovascular risk. For men taking these medications, questions often arise about their potential impact on sexual function, particularly erectile dysfunction (ED). The relationship between statins and erectile function is complex and sometimes misunderstood, with concerns frequently raised in clinical consultations.

Erectile dysfunction affects a significant proportion of men, particularly those over 40 years of age, and shares many risk factors with cardiovascular disease—including high cholesterol, hypertension, diabetes, and smoking. This overlap means that men prescribed statins often already have underlying conditions that predispose them to ED, making it challenging to determine whether the medication itself contributes to sexual difficulties or whether the underlying cardiovascular disease is the primary cause.

Statins work by inhibiting HMG-CoA reductase, an enzyme crucial for cholesterol synthesis in the liver. By lowering low-density lipoprotein (LDL) cholesterol and improving endothelial function, statins reduce atherosclerotic plaque formation throughout the vascular system. Since erectile function depends heavily on adequate blood flow to the penile arteries, the vascular benefits of statins may theoretically improve erectile function rather than impair it.

It is important to recognise that whilst some men report sexual side effects when taking statins, the evidence does not demonstrate a strong causal link between statin therapy and erectile dysfunction. Sexual dysfunction is listed in some statin Summaries of Product Characteristics (SmPCs) with low frequency. The perception of such a connection may also be influenced by nocebo effects, where awareness of potential side effects leads to their perceived occurrence. Understanding this relationship requires examining both the pharmacological effects of statins and the broader context of cardiovascular health as described in NHS and NICE Clinical Knowledge Summary (CKS) guidance.

Do Statins Improve or Worsen Erectile Function?

The question of whether statins help or hinder erectile function does not have a straightforward answer, as the evidence presents a nuanced picture. Some men experience concerns about sexual function after starting statin therapy, whilst emerging research suggests that statins may actually offer benefits for erectile function in certain circumstances.

Potential concerns about statins and ED have been raised because cholesterol is a precursor to testosterone synthesis. Theoretically, significantly lowering cholesterol might reduce testosterone production, potentially affecting libido and erectile function. However, clinical studies have generally shown only small, usually clinically insignificant changes in testosterone levels with standard statin doses. The Medicines and Healthcare products Regulatory Agency (MHRA) product information for some statins lists sexual dysfunction as a possible side effect, though typically with 'rare' or 'unknown' frequency.

Conversely, potential benefits of statin therapy for erectile function are increasingly recognised. By improving endothelial function and reducing arterial inflammation, statins may enhance blood flow throughout the body, including to the penile vasculature. Men with erectile dysfunction often have endothelial dysfunction—a condition where blood vessels cannot dilate properly—which statins are known to improve. This vascular benefit may outweigh any theoretical hormonal concerns.

Clinical experience suggests that when men develop ED after starting statins, the underlying cardiovascular disease progression is often the more likely culprit. Erectile dysfunction can serve as an early warning sign of systemic vascular disease, sometimes appearing years before cardiac symptoms. Therefore, rather than viewing statins as a cause of ED, it may be more accurate to recognise that both the medication and the sexual symptoms reflect the presence of cardiovascular risk factors requiring management. Individual responses vary, and any concerns should be discussed openly with a healthcare professional rather than discontinuing medication without medical advice.

How Cholesterol and Cardiovascular Health Affect Erections

Understanding erectile function requires appreciating the crucial role of vascular health. An erection is fundamentally a vascular event, requiring adequate blood flow through healthy, flexible arteries. The penile arteries are relatively small (1–2mm in diameter), making them particularly vulnerable to the effects of atherosclerosis—the process by which cholesterol-laden plaques narrow and stiffen blood vessels.

High cholesterol levels, particularly elevated LDL cholesterol, contribute significantly to atherosclerotic disease throughout the arterial system. When cholesterol deposits accumulate in arterial walls, they trigger inflammatory responses and endothelial dysfunction. The endothelium—the inner lining of blood vessels—plays a vital role in erectile function by producing nitric oxide, a molecule essential for smooth muscle relaxation and arterial dilation. Impaired endothelial function reduces nitric oxide availability, directly compromising erectile capacity.

The connection between cardiovascular disease and erectile dysfunction is so well established that ED is now recognised as a potential marker of cardiovascular risk. NICE Clinical Knowledge Summary (CKS) on erectile dysfunction acknowledges that men presenting with ED should be assessed for cardiovascular risk factors, including using QRISK3 for 10-year cardiovascular risk estimation in UK primary care. Erectile difficulties may precede cardiac events by several years. This "penile-cardiac connection" reflects the systemic nature of vascular disease—if small penile arteries are affected, larger coronary arteries may also be compromised.

Additional cardiovascular risk factors compound the problem. Hypertension damages arterial walls, diabetes causes both vascular and nerve damage affecting erectile function, and smoking accelerates atherosclerosis whilst also causing acute vasoconstriction. Obesity, physical inactivity, and metabolic syndrome further contribute to both cardiovascular disease and ED through multiple mechanisms including hormonal changes, inflammation, and insulin resistance.

By addressing these cardiovascular risk factors—through lifestyle modifications and medications like statins—men can potentially improve both their heart health and erectile function. The vascular improvements achieved through cholesterol management may restore some degree of erectile capacity, particularly when combined with other interventions such as increased physical activity (UK Chief Medical Officers recommend at least 150 minutes weekly), smoking cessation, and optimal diabetes control.

What the Research Says About Statins and ED

The scientific literature on statins and erectile dysfunction presents findings that may surprise those who assume these medications worsen sexual function. Multiple studies have examined this relationship, with results generally suggesting either neutral or beneficial effects of statin therapy on erectile function.

A systematic review and meta-analysis by Kostis et al. published in the Journal of Sexual Medicine analysed data from multiple randomised controlled trials and observational studies. The findings indicated that statin therapy was associated with modest improvements in erectile function scores (approximately 3.4 points on the International Index of Erectile Function scale), particularly in men with underlying cardiovascular disease or dyslipidaemia. The proposed mechanism involves improved endothelial function and enhanced nitric oxide bioavailability—both crucial for normal erectile physiology.

Observational studies have yielded mixed results, partly due to methodological challenges. Some studies reported increased ED complaints among statin users, but these findings are difficult to interpret because men prescribed statins typically have multiple cardiovascular risk factors that independently cause ED. When researchers control for these confounding variables—age, diabetes, hypertension, smoking—the apparent negative association between statins and erectile function often diminishes or disappears.

Research specifically examining different statin types has not identified consistent differences in their effects on sexual function, though the evidence is limited by heterogeneity and few direct comparative studies. Lipophilic statins (such as atorvastatin and simvastatin) and hydrophilic statins (such as rosuvastatin and pravastatin) appear to have similar profiles regarding erectile function. There is no robust evidence suggesting that switching between statin types improves sexual function, though individual responses may vary.

Important limitations exist in the current evidence base. Many studies rely on self-reported outcomes, which can be influenced by expectations and beliefs about medication side effects. Additionally, the nocebo effect—where negative expectations lead to perceived adverse effects—may play a role when men are aware of potential sexual side effects listed in patient information leaflets. Study quality varies considerably, with many having small sample sizes or inadequate control for confounding factors.

The balance of evidence suggests that for most men, statins do not cause erectile dysfunction and may actually provide modest benefits through vascular improvements. However, if a man experiences new or worsening ED after starting statin therapy, this warrants medical review—not necessarily to discontinue the statin, but to ensure comprehensive cardiovascular assessment and appropriate ED management.

Managing Erectile Dysfunction While Taking Statins

For men experiencing erectile dysfunction whilst taking statins, a comprehensive management approach addresses both cardiovascular health and sexual function without compromising either. Discontinuing statins without medical advice is not recommended, as this may increase cardiovascular risk, including the risk of heart attack and stroke.

The first step involves thorough assessment by a GP or appropriate healthcare professional. This should include:

• Review of all medications, as numerous drugs beyond statins can affect erectile function (including beta-blockers, thiazide diuretics, and antidepressants)

• Evaluation of cardiovascular risk factors and their control (blood pressure, diabetes management, cholesterol levels)

• Assessment of hormonal status, particularly morning total testosterone levels (repeated if low)

• Investigations including HbA1c/glucose, fasting lipids, and thyroid/prolactin tests if clinically indicated

• Discussion of psychological factors, relationship issues, and stress, which commonly contribute to ED

• Lifestyle factors including alcohol consumption, smoking, physical activity, and sleep quality

Lifestyle modifications form the foundation of ED management and complement statin therapy. Evidence supports several interventions:

• Regular physical activity: Aerobic exercise improves endothelial function and erectile capacity. UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly.

• Weight management: Losing excess weight improves testosterone levels, vascular function, and confidence.

• Smoking cessation: Stopping smoking provides both immediate and long-term benefits for erectile function.

• Alcohol moderation: Limiting alcohol intake to within recommended guidelines (14 units weekly) may improve sexual function.

• Mediterranean diet: This eating pattern supports cardiovascular health and may benefit erectile function.

Pharmacological treatments for ED can be safely used alongside statins. Phosphodiesterase-5 (PDE5) inhibitors—including sildenafil, tadalafil, and vardenafil—are first-line treatments. Generic sildenafil can generally be prescribed on the NHS, while some other PDE5 inhibitors may remain subject to Selected List Scheme (SLS) restrictions. Sildenafil 50mg (Viagra Connect) is also available from pharmacists without prescription. PDE5 inhibitors are absolutely contraindicated in men taking nitrates or riociguat due to dangerous blood pressure drops, and caution is needed with alpha-blockers. Men should be assessed for cardiovascular stability before resuming sexual activity.

When to seek medical advice: Men should contact their GP if they experience new or worsening erectile dysfunction, as this may indicate progression of cardiovascular disease requiring investigation. Urgent medical attention is needed for priapism (erection lasting >4 hours) or chest pain during sexual activity. Consider urology/endocrinology referral for suspected structural disease, endocrine causes, or non-response to maximal PDE5 therapy. Similarly, any concerns about statin side effects should be discussed rather than leading to medication discontinuation. Suspected adverse effects can be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

A collaborative approach between patient and healthcare provider, focusing on optimising both cardiovascular health and quality of life, typically yields the best outcomes. Erectile dysfunction should be viewed as a manageable condition and an opportunity to address overall health, rather than a reason to avoid necessary cardiovascular medications.

Frequently Asked Questions